The 39th Annual Conference: Clinical Hematology and Oncology 2019 covers topics such as:
- Changing approaches to hematologic malignancies, particularly as they relate to evidence-based standards of care, including innovations in diagnosis and treatment
- Clinical and molecular facets of pathogenesis, diagnostic approaches and therapeutic modalities available for various hematologic disorders
- Practical expertise gained from the clinical situations discussed in the workshop sessions with an emphasis on data-based approaches to patients with common but serious hematologic conditions
- New therapeutic options for the treatment of a number of common malignancies; understanding appropriate indications and contraindications to these therapeutic approaches
- Evolving approaches to various immunologic cancer treatments
- Evolving approaches to breast cancer from both a diagnostic, prognostic and therapeutic perspective
The 39th Annual Conference: Clinical Hematology and Oncology 2019 brings together clinicians and leading experts in diverse areas of hematology and oncology.